Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Institutional Investors Approve of SEC’s Shareholder Proxy Changes

Agreed, let's discuss the outcome of your request to the SEC once you have provided their response.

I also look forward to doing the same after the outcome of the Rule 14a-11 proposal is known.

.

.

.

Be well

Share
New Message
Please login to post a reply